AKYA - Pendapatan operasional sadurunge ngurangi amortisasi Akoya Biosciences

Akoya Biosciences operates on a "razor-and-blade" model, where system sales lock customers into purchasing consumables. Cash operating profit demonstrates the resilience of a business protected by reagent patents. Constant demand for cartridges ensures a steady cash flow, and serves as the final mark for this financial metric.
Akoya Biosciences, Inc. (AKYA) - rincian metrik lan laporan keuangan
- rega saiki lan proyeksi nilai saham:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Akoya Biosciences|AKYA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Akoya Biosciences Inc|AKYA - Gunggung utang perusahaan|Rasio utang marang nilai buku Akoya Biosciences|AKYA - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Akoya Biosciences|Indikator likuiditas cepet akoyabio.com
- data bathi lan kelipatan valuasi:
AKYA - Bathi resik|Proyeksi bathi mangsa ngarep Akoya Biosciences|AKYA - Rasio rega marang bathi|Rega marang bathi mangsa ngarep Akoya Biosciences Inc|AKYA - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Akoya Biosciences|AKYA - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Akoya Biosciences|AKYA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku akoyabio.com|AKYA - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Akoya Biosciences
Ringkesan analitik perusahaan:Akoya Biosciences - AKYA

This indicator reflects the net cash result from core operations before depreciation and interest, allowing for an assessment of the actual scale of cash generation. For Akoya Biosciences (AKYA), this process is fueled by high customer loyalty to consumables, which makes the company's total operating profit an indicator of ecosystem resilience and confirms the high value of its technological assets.
Karo sapa Akoya Biosciences saingan
Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ABT (Abbott Corp.)|Thermo Fisher Scientific - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi gehealthcare.com GEHC|MTD: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Waters Corp|Bathi operasional sadurunge ngurangi amortisasi TECH|BRKR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Azenta, Inc. (AZTA)|Bathi operasional sadurunge ngurangi amortisasi vareximaging.com VREX|Bathi operasional EBITDA SMLR (Semler Scientific)|Butterfly Network Inc (BFLY) - Bathi sadurunge bunga, pajak, lan amortisasi|Mesa Labs Corp - Bathi operasional EBITDA|QSI (Quantum-Si Corporation) - Bathi operasional sadurunge amortisasi|NNOX: Bathi operasional EBITDA|QTRX - Pendapatan operasional sadurunge ngurangi amortisasi|MASS (908 Devices) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi CapsoVision Medical (CV)|Bathi operasional EBITDA MXCT|Bathi operasional EBITDA rapidmicrobio.com (RPID)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Seer, Inc. SEER|hyperfine.io - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|FONR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi DXR (Daxor Corporation)|MDAI: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Organovo Holdings Inc. (VIVS)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aclarion|THMO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi TLIS (Talis Biomedical)|Bathi operasional EBITDA T2 Biosystems Inc. (TTOO)